agilon health (NYSE:AGL) Stock Rating Lowered by Bank of America
agilon health (NYSE:AGL – Get Free Report) was downgraded by investment analysts at Bank of America from a “buy” rating to an “underperform” rating in a report issued on Wednesday, Marketbeat.com reports. They presently have a $3.00 price objective on the stock. Bank of America‘s price objective would suggest a potential downside of 5.21% from […]
4 Oct 06:54 · The Markets Daily